BESEQUMA
Live / Allowed — Approved for publication (as of 13 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79458060
- Mark type
- Design + words
- Filed
- 09 Jul 2026
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of hidradenitis suppurativa; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of autoimmune diseases
Owner
- CELLTRION, INC., KR
Prosecution history
- 13 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2026 — ASSIGNED TO EXAMINER
- 06 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Oct 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 10 Sept 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB